New eBook: Efficiently develop antibody-based therapeutics 


In the Quality by Design (QbD) approach to antibody-based therapeutics development, stability characterisation —the probability of a protein unfolding or denaturing— is performed to ensure that structure and function are preserved throughout development and manufacturing. 

Antibodies are affected by many factors along their journey to become therapeutics. Stability characterisation assays are therefore pivotal to determine the optimal formulations and storage conditions for each therapeutic. 

Download this new eBook from Nanotemper to learn: 

  • Various techniques to measure stability 
  • Approaches for monoclonal antibody formulation 
  • How stability studies support Investigational New Drug (IND) and Biological License Application (BLA) filings 
  • How storage conditions affect mAb stability 

Download the eBook here. 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free